JEFFREY L. KELLY, Ph.D.

Ellicott City, Maryland 21042

410-531-9396
jkad487a@westpost.net
www.linkedin.com/in/jeffreykelly78

SUMMARY
RESEARCH AND DEVELOPMENT EXECUTIVE with 13 years experience identifying and comm
ercializing technology platforms. Leverage experience in both R&D and Business
Development to effectively formulate and implement business plans for technology
discoveries. Apply outstanding creativity and resoluteness to drive concepts t
o fruition. Communicate ideas and analysis persuasively to diverse audiences.
Proven dealmaker with experience in composing, negotiating and closing.
- Improved R&D's on-time project completion rate.
- Controlled R&D spending within budget.
- Spearheaded technology identification and acquisition projects resulting in fo
ur significant licensing agreements.
- Delivered due diligence analysis for a $100 Million acquisition and for a part
nership creating a $20 Million business.
PROFESSIONAL EXPERIENCE
LONZA (formerly Cambrex BioScience), Walkersville, Maryland, 2000 - 2009
TECHNICAL DIRECTOR, BUSINESS DEVELOPMENT (2007 - 2009)
Performed due diligence and technical support for acquisitions and licensing. M
anaged technology portfolio, project management system, and strategic planning.
Led business deal teams from identification through execution. Provided techni
cal direction for integration of new technologies.
- Generated and established business plan for human pluripotent stem cells. Ini
tiated multiple agreements with technology owners.
- Analyzed technology need areas of cell based assays, and molecular microbial d
etection systems. Identified and assessed target technology owners. Final deal
terms reached with technology owners in both fields.
- Completed two acquisitions, four licensing agreements, and one divestiture.
- Obtained $1.5 Million grant from the Armed Forces Institute for Regenerative M
edicine for preclinical development of a skin cell therapy product.
- Represented organization on Lonza Innovation for Future Technologies program;
participated in selection and review of grant funding to outside collaborators.
- Technical lead for Cambrex integration team; developed synergies with Lonza's
BioPharmaceutical contract manufacturing business sector.
GLOBAL DIRECTOR, RESEARCH & DEVELOPMENT (2004 - 2007)
TECHNICAL DIRECTOR, MOLECULAR BIOLOGY (2000 - 2004)
Led R&D Department to support sector business strategy including new product and
technology strategic planning, project management, budgeting, staffing, mentori
ng group leaders, intellectual property, and external collaborations.
- Directed R&D Department of 50 scientists at four international locations. Ann
ual budget was > $10 Million. Spending was within budget each year.
- Launched > 50 innovative Research Products including human cell culture system
s, cell based assays, luciferase assays, rapid microbial detection systems and e
lectrophoretic separation systems, contributing > $10 Million in 2007 revenues.
- Improved on-time project phase completion rate to meet target performance metr
ic by driving the R&D project management system.
- Promoted innovation and invention in department yielding nine issued US patent
s and two published applications.
- Managed multiple external collaborations with international scientists from ac
ademia, industry, and government.
- Participated in Management Team presentations during sale of business.
PROMEGA CORPORATION, Madison, Wisconsin, 1997 - 2000
R&D DIRECTOR (PLATFORM MANAGER, PROTEOMICS) (1999 - 2000)
Also CUSTOMER FOCUS TEAM LEADER, MOLECULAR BIOLOGY (1998 - 2000); R&D GROUP MANA
GER, PROTEIN EXPRESSION (1997 - 1999)
- Developed new products and technology in areas of protein expression systems (
E. coli, Pichia, baculovirus, mammalian cell line), enzyme engineering (directed
evolution), luciferase assays, and in vitro protein expression.
- Launched > 10 recombinant enzymes, steady glow and bright glow luciferase assa
ys, and an automated system for protein production from cDNA pools.
- Directed group of 25 scientists and served on four-person department managemen
t team.
- Held P&L responsibility for the Molecular Biology Business Unit. BU 1999 sale
s revenues were > $20 Million; revenue growth met plan for 1998 - 2000.
- Represented R&D on ISO implementation team.
ADDITIONAL RELEVANT EXPERIENCE
R&D Group Leader, Molecular Biology, Biosys, Inc., Columbia, Maryland, 1995 - 19
97
Director, Molecular Genetics, Crop Genetics International, Columbia, Maryland, 1
988 - 1995
EDUCATION
Ph.D., Biochemistry, Stanford University, Stanford, California
B.S., Biochemistry, Cornell University, Ithaca, New York
HONORS
McKnight Foundation Post-doctoral Fellowship
National Science Foundation Graduate Fellowship
Bachelor of Science with Distinction
Phi Kappa Phi, College of Agriculture & Life Sciences Honor Society
Laubengayer Prize, Outstanding Freshman Chemistry Student Award